Kallikrein Inhibitors (Toronto Innovation/Evotec)

N/A

Report date: 2025/01/26 15:14:10
NME

Base Information

Drug NameKallikrein Inhibitors (Toronto Innovation/Evotec)
Drug Alias NameKallikrein Inhibitors (MaRs Innovation/Evotec)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKallikreins inhibitors
TargetsKallikreins
Therapy Area/IndicationsDermatitis, AtopicNetherton Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMount Sinai Hospital
China Registration ClassN/A

Develop Information

Active CompaniesToronto Innovation Acceleration PartnersEvotec SE
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicNetherton Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A